This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)

From Oxford Club | Ad

Analysts predict earnings will soar more than 320% this year...Possibly as much as 500%!

Discover the last opportunity that could still rocket skyward in THIS market.

Click Here to Discover Details on the Shocking Less Than $2 Stock.

>>>

BHVN Insider Trading (Biohaven Pharmaceutical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.40%

Insider Buying (Last 12 Months): $614,350.00

Insider Selling (Last 12 Months): $16,498,698.66

Biohaven Pharmaceutical Insider Trading History Chart

Biohaven Pharmaceutical Share Price & Price History

^$140.92

▼ -0.08 (-0.06%)

As of 05/16/2022 03:33 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

Biohaven Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2022	George C. Clark	CAO	Sell	4,200	$141.50	$594,300.00	4,065
1/19/2022	George C. Clark	CAO	Sell	9,375	$117.01	$1,096,968.75
12/20/2021	George C. Clark	CAO	Sell	1,915	$123.84	$237,153.60
12/20/2021	Julia P. Gregory	Director	Sell	12,000	$125.00	$1,500,000.00
12/15/2021	Elyse Stock	Insider	Sell	21,919	$105.49	$2,312,235.31
12/10/2021	James Engelhart	CFO	Sell	35,000	$102.55	$3,589,250.00
11/29/2021	Declan Doogan	Director	Sell	24,525	$112.80	$2,766,420.00
11/16/2021	Declan Doogan	Director	Sell	37,740	$116.65	$4,402,371.00
11/10/2021	John W. Childs	Director	Buy	5,000	$122.87	$614,350.00
3/17/2021	John W. Childs	Director	Buy	13,157	$76.00	$999,932.00
3/2/2021	John W. Childs	Director	Buy	10,000	$85.14	$851,400.00	2,532,644
11/23/2020	John W. Childs	Director	Buy	5,000	$89.55	$447,750.00	2,516,938
11/2/2020	William A. Jones, Jr.	Insider	Sell	30,000	$76.22	$2,286,600.00	31,755
10/22/2020	Gregory H. Bailey	Director	Sell	24,566	$79.47	$1,952,260.02	2,559,161
10/19/2020	Gregory H. Bailey	Director	Sell	4,554	$78.98	$359,674.92	2,585,181
10/16/2020	Gregory H. Bailey	Director	Sell	3,748	$78.88	$295,642.24	2,585,181
10/12/2020	Gregory H. Bailey	Director	Sell	6,729	$78.87	$530,716.23	2,588,929
10/8/2020	Kimberly Gentile	SVP	Sell	23,500	$76.34	$1,793,990.00	27,139
9/21/2020	John W. Childs	Director	Buy	3,322	$59.25	$196,828.50	2,511,938
9/11/2020	John W. Childs	Director	Buy	6,678	$59.00	$394,002.00	2,508,616
7/8/2020	Gregory H. Bailey	Director	Sell	50,000	$75.22	$3,761,000.00	2,601,649
7/8/2020	Robert Berman	Insider	Sell	58,404	$75.25	$4,394,901.00	58,745
6/24/2020	Gregory H. Bailey	Director	Sell	3,995	$69.86	$279,090.70	2,737,829
6/23/2020	Robert Berman	Insider	Sell	4,296	$75.05	$322,414.80	4,637
6/22/2020	Gregory H. Bailey	Director	Sell	80,331	$73.24	$5,883,442.44	2,973,646
6/19/2020	Gregory H. Bailey	Director	Sell	164,031	$71.22	$11,682,287.82	2,973,646
6/18/2020	Robert Berman	Insider	Sell	61,314	$75.27	$4,615,104.78	36,655
6/17/2020	Kimberly Gentile	SVP	Sell	24,000	$70.20	$1,684,800.00	27,639
6/15/2020	Declan Doogan	Director	Sell	80,000	$66.73	$5,338,400.00	373,913
6/12/2020	Declan Doogan	Director	Sell	160,000	$66.00	$10,560,000.00	373,913
6/12/2020	Elyse Stock	Insider	Sell	36,966	$66.00	$2,439,756.00	22,560
6/11/2020	James Engelhart	CFO	Sell	73,725	$66.00	$4,865,850.00	15,975
6/10/2020	John Tilton	Insider	Sell	52,000	$67.38	$3,503,760.00	52,770
6/8/2020	Kimberly Gentile	SVP	Sell	600	$70.05	$42,030.00	4,239
4/6/2020	John W. Childs	Director	Sell	150,000	$31.25	$4,687,500.00	2,682,279
1/22/2020	Eric Aguiar	Director	Sell	2,021	$56.48	$114,146.08
1/9/2020	Eric Aguiar	Director	Sell	30,000	$56.39	$1,691,700.00	30,000
12/30/2019	Robert Berman	Insider	Sell	125,000	$53.22	$6,652,500.00	125,341
12/16/2019	Eric Aguiar	Director	Sell	3,537	$55.13	$194,994.81
12/9/2019	Eric Aguiar	Director	Sell	4,072	$55.11	$224,407.92
11/22/2019	Eric Aguiar	Director	Sell	1,250	$55.24	$69,050.00	12,000
11/20/2019	Eric Aguiar	Director	Sell	6,729	$52.20	$351,253.80
11/20/2019	Kimberly Gentile	SVP	Sell	3,935	$53.03	$208,673.05	3,935
10/18/2019	Elyse Stock	Insider	Sell	17,700	$45.07	$797,739.00	17,700
10/15/2019	Elyse Stock	Insider	Sell	800	$45.01	$36,008.00	800
9/11/2019	Eric Aguiar	Director	Sell	10,000	$45.00	$450,000.00
8/20/2019	Gregory H. Bailey	Director	Buy	5,000	$37.65	$188,250.00	2,587,601
6/27/2019	James Engelhart	CFO	Buy	2,500	$43.05	$107,625.00
6/26/2019	John W. Childs	Director	Buy	10,000	$40.37	$403,700.00
6/26/2019	Vlad Coric	CEO	Buy	5,000	$40.22	$201,100.00

Warning: The Last Value Play Gone After August?

From Oxford Club | Ad

In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.

But a key announcement in August could send this stock rocketing skyward.

Get the Details Now.

SEC Filings (Institutional Ownership Changes) for Biohaven Pharmaceutical (NYSE:BHVN)

88.03% of Biohaven Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biohaven Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2022	Wellington Management Group LLP	135,284	$16.04M	0.0%	+32.8%	0.192%
5/16/2022	State Street Corp	1,655,834	$196.33M	0.0%	+0.5%	2.348%
5/16/2022	Eversept Partners LP	644,666	$76.44M	6.3%	+104.6%	0.914%
5/16/2022	Suvretta Capital Management LLC	61,631	$7.31M	0.2%	N/A	0.087%
5/16/2022	Engineers Gate Manager LP	24,089	$2.86M	0.1%	N/A	0.034%
5/16/2022	Cresset Asset Management LLC	4,305	$0.51M	0.0%	-15.5%	0.006%
5/16/2022	Capital Group Private Client Services Inc.	68,561	$8.13M	0.1%	+1.8%	0.097%
5/16/2022	Myriad Asset Management Ltd.	22,127	$2.62M	0.4%	+53.7%	0.031%
5/16/2022	Hood River Capital Management LLC	231,537	$27.45M	0.9%	-22.8%	0.328%
5/16/2022	Invesco Ltd.	147,932	$17.54M	0.0%	-34.4%	0.210%
5/16/2022	UBS Group AG	37,629	$4.46M	0.0%	+220.4%	0.053%
5/16/2022	Hsbc Holdings PLC	4,557	$0.55M	0.0%	-33.3%	0.006%
5/13/2022	Silverarc Capital Management LLC	102,497	$4.36M	1.8%	+27.6%	0.145%
5/13/2022	Rhenman & Partners Asset Management AB	136,000	$16.13M	1.6%	-9.3%	0.193%
5/13/2022	Bellevue Group AG	39,207	$4.65M	0.1%	+3.2%	0.056%
5/13/2022	Northern Trust Corp	526,552	$62.43M	0.0%	-9.4%	0.747%
5/13/2022	Industrial Alliance Investment Management Inc.	36,140	$4.29M	0.1%	N/A	0.051%
5/13/2022	Verition Fund Management LLC	2,396	$0.28M	0.0%	-68.6%	0.003%
5/13/2022	Charles Schwab Investment Management Inc.	603,825	$71.60M	0.0%	+6.9%	0.856%
5/13/2022	Arrowstreet Capital Limited Partnership	2,271	$0.27M	0.0%	N/A	0.003%
5/13/2022	Clearbridge Investments LLC	1,151,829	$136.57M	0.1%	+32.0%	1.633%
5/13/2022	First Trust Advisors LP	41,220	$4.89M	0.0%	-24.5%	0.058%
5/13/2022	Prudential Financial Inc.	5,580	$0.66M	0.0%	+25.2%	0.008%
5/13/2022	American International Group Inc.	27,653	$3.28M	0.0%	-6.6%	0.039%
5/13/2022	Bridgewater Associates LP	5,900	$0.70M	0.0%	+43.3%	0.008%
5/13/2022	Mackenzie Financial Corp	23,108	$2.74M	0.0%	+624.8%	0.033%
5/13/2022	Vanguard Group Inc.	1,421,726	$168.57M	0.0%	+3.8%	2.016%
5/13/2022	EAM Investors LLC	12,216	$1.45M	0.3%	N/A	0.017%
5/13/2022	Symmetry Investments LP	10,000	$1.19M	0.2%	N/A	0.014%
5/13/2022	Sei Investments Co.	17,329	$2.05M	0.0%	+20.2%	0.025%
5/13/2022	Lord Abbett & CO. LLC	453,102	$53.72M	0.1%	+62.8%	0.642%
5/13/2022	Blair William & Co. IL	125,109	$14.83M	0.1%	-18.2%	0.177%
5/13/2022	Dimensional Fund Advisors LP	82,599	$9.79M	0.0%	+55.3%	0.117%
5/12/2022	BlackRock Inc.	4,656,866	$552.16M	0.0%	+0.5%	6.603%
5/12/2022	Rhumbline Advisers	62,468	$7.41M	0.0%	-2.1%	0.089%
5/12/2022	E Fund Management Co. Ltd.	2,259	$0.27M	0.0%	+29.9%	0.003%
5/12/2022	Eagle Asset Management Inc.	318,354	$37.75M	0.2%	-4.5%	0.451%
5/12/2022	AlphaCrest Capital Management LLC	2,902	$0.34M	0.0%	N/A	0.004%
5/12/2022	PNC Financial Services Group Inc.	735	$88K	0.0%	-24.0%	0.001%
5/12/2022	Cetera Advisor Networks LLC	2,804	$0.33M	0.0%	N/A	0.004%
5/12/2022	Lisanti Capital Growth LLC	75,947	$9.01M	1.0%	-9.8%	0.108%
5/11/2022	ACT Capital Management LLC	2,100	$0.25M	0.3%	N/A	0.003%
5/11/2022	US Bancorp DE	586	$70K	0.0%	+19.1%	0.001%
5/11/2022	American Century Companies Inc.	684,834	$81.20M	0.1%	+259.4%	0.971%
5/11/2022	Bank of New York Mellon Corp	1,154,954	$136.94M	0.0%	-3.7%	1.638%
5/11/2022	Handelsbanken Fonder AB	278,600	$33.03M	0.2%	-3.0%	0.395%
5/11/2022	Nvwm LLC	7,208	$0.86M	0.3%	-29.8%	0.010%
5/11/2022	Raymond James & Associates	38,867	$4.61M	0.0%	+5.9%	0.055%
5/11/2022	L & S Advisors Inc	25,934	$3.08M	0.4%	-38.9%	0.037%
5/11/2022	Skandinaviska Enskilda Banken AB publ	131,186	$15.56M	0.1%	-15.4%	0.186%
5/11/2022	JPMorgan Chase & Co.	1,369,533	$162.39M	0.0%	-1.8%	1.942%
5/10/2022	Sectoral Asset Management Inc.	105,850	$12.55M	2.2%	N/A	0.150%
5/10/2022	Nicholas Investment Partners LP	176,283	$20.90M	1.5%	-22.3%	0.250%
5/10/2022	Profund Advisors LLC	9,293	$1.10M	0.0%	-6.1%	0.013%
5/10/2022	ProShare Advisors LLC	11,849	$1.41M	0.0%	-13.0%	0.017%
5/10/2022	CNA Financial Corp	3,000	$0.36M	0.1%	-47.6%	0.004%
5/10/2022	AGF Investments LLC	6,291	$0.75M	0.1%	-9.9%	0.009%
5/10/2022	Pier Capital LLC	36,491	$4.33M	0.6%	-57.5%	0.052%
5/10/2022	Saturna Capital CORP	1,750	$0.21M	0.0%	-15.9%	0.002%
5/10/2022	People s United Financial Inc.	3,460	$0.41M	0.0%	+38.6%	0.005%
5/10/2022	Fox Run Management L.L.C.	2,677	$0.32M	0.2%	N/A	0.004%
5/10/2022	Level Four Advisory Services LLC	6,947	$0.82M	0.1%	+3.0%	0.010%
5/10/2022	EULAV Asset Management	185,000	$21.94M	0.7%	-26.6%	0.262%
5/9/2022	Fiera Capital Corp	37,111	$4.40M	0.0%	-3.8%	0.053%
5/9/2022	FSC Wealth Advisors LLC	3,300	$0.39M	0.4%	+10.0%	0.005%
5/9/2022	Campbell & CO Investment Adviser LLC	4,020	$0.48M	0.1%	N/A	0.006%
5/9/2022	Bank of Nova Scotia	5,299	$0.63M	0.0%	-33.6%	0.008%
5/9/2022	GW&K Investment Management LLC	406,256	$48.17M	0.4%	+6.8%	0.576%
5/9/2022	Principal Financial Group Inc.	25,572	$3.03M	0.0%	-18.0%	0.036%
5/9/2022	Swiss National Bank	139,400	$16.53M	0.0%	+7.6%	0.198%
5/9/2022	Duality Advisers LP	8,167	$0.97M	0.1%	N/A	0.012%
5/9/2022	Teacher Retirement System of Texas	12,200	$1.45M	0.0%	+8.4%	0.017%
5/9/2022	Brown Advisory Inc.	855,563	$101.60M	0.1%	+0.8%	1.213%
5/9/2022	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	28,100	$3.33M	0.0%	-33.7%	0.040%
5/6/2022	HC Advisors LLC	2,694	$0.32M	0.2%	-38.6%	0.004%
5/6/2022	WCM Investment Management LLC	56,823	$6.74M	0.0%	-12.3%	0.081%
5/6/2022	State Board of Administration of Florida Retirement System	17,893	$2.12M	0.0%	-10.6%	0.025%
5/5/2022	Compass Financial Advisors LLC	3,253	$0.39M	0.4%	-16.7%	0.005%
5/5/2022	Washington Trust Advisors Inc.	810	$96K	0.0%	+24.6%	0.001%
5/5/2022	Fisher Asset Management LLC	368,257	$43.66M	0.0%	-1.1%	0.522%
5/5/2022	Rice Hall James & Associates LLC	277,006	$32.85M	1.4%	-1.8%	0.393%
5/5/2022	New York State Common Retirement Fund	69,226	$8.21M	0.0%	+5.3%	0.098%
5/5/2022	Russell Investments Group Ltd.	108,622	$12.88M	0.0%	+17.5%	0.154%
5/4/2022	California Public Employees Retirement System	117,458	$13.93M	0.0%	+7.4%	0.167%
5/4/2022	ClariVest Asset Management LLC	2,513	$0.30M	0.0%	-42.8%	0.004%
5/4/2022	Prospera Financial Services Inc	1,349	$0.16M	0.0%	N/A	0.002%
5/4/2022	Victory Capital Management Inc.	2,564	$0.23M	0.0%	+6.4%	0.004%
5/4/2022	Commonwealth Equity Services LLC	6,253	$0.74M	0.0%	+6.8%	0.009%
5/4/2022	Banque Pictet & Cie SA	16,400	$1.95M	0.0%	+4.0%	0.023%
5/4/2022	Envestnet Asset Management Inc.	29,849	$3.54M	0.0%	+12.5%	0.042%
5/4/2022	Shell Asset Management Co.	2,344	$0.28M	0.0%	-12.9%	0.003%
5/4/2022	C WorldWide Group Holding A S	172,498	$20.45M	0.2%	-18.8%	0.245%
5/3/2022	State of New Jersey Common Pension Fund D	36,100	$4.28M	0.0%	-2.8%	0.051%
5/3/2022	Values First Advisors Inc.	4,317	$0.51M	0.3%	+7.9%	0.006%
5/3/2022	Calamos Advisors LLC	27,800	$3.30M	0.0%	N/A	0.039%
5/2/2022	Mutual of America Capital Management LLC	35,127	$4.17M	0.0%	-29.8%	0.050%
4/29/2022	SG Americas Securities LLC	11,468	$1.36M	0.0%	-41.7%	0.016%
4/29/2022	Park Avenue Securities LLC	2,122	$0.25M	0.0%	+24.9%	0.003%
4/29/2022	Emerald Mutual Fund Advisers Trust	262,890	$31.17M	1.4%	+0.9%	0.373%
4/29/2022	Emerald Advisers LLC	316,386	$37.51M	1.4%	+23.3%	0.449%

Data available starting January 2016

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

Today's Range

Now: $140.92

$140.80

$141.24

50 Day Range

MA: $113.74

$83.14

$141.00

52 Week Range

Now: $140.92

$65.68

$151.51

Volume

263,193 shs

Average Volume

1,130,198 shs

Market Capitalization

$9.94 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Biohaven Pharmaceutical?: Biohaven Pharmaceutical's top insider shareholders include:
Gregory Bailey (Director)
John W Childs (Director)
Declan Doogan (Director)
Robert Berman (Insider)
John Tilton (Insider)
William A Jones Jr (Insider)
Kimberly Gentile (SVP)
Elyse Stock (Insider)
James Engelhart (CFO)
George C Clark (CAO)
Julia P Gregory (Director)
Learn More about top insider investors at Biohaven Pharmaceutical.
Who are the major institutional investors of Biohaven Pharmaceutical?: Biohaven Pharmaceutical's top institutional shareholders include:
BlackRock Inc. — 6.60%
State Street Corp — 2.35%
Vanguard Group Inc. — 2.02%
JPMorgan Chase & Co. — 1.94%
Bank of New York Mellon Corp — 1.64%
Clearbridge Investments LLC — 1.63%
Learn More about top institutional investors of Biohaven Pharmaceutical stock.
Which major investors are selling Biohaven Pharmaceutical stock?: During the last quarter, BHVN stock was sold by these institutional investors:
Invesco Ltd.
Hood River Capital Management LLC
EULAV Asset Management
Northern Trust Corp
Nicholas Investment Partners LP
Pier Capital LLC
Bank of New York Mellon Corp
C WorldWide Group Holding A S
In the last year, company insiders that have sold Biohaven Pharmaceutical company stock include:
Gregory Bailey (Director)
John W Childs (Director)
Declan Doogan (Director)
Robert Berman (Insider)
John Tilton (Insider)
Learn More investors selling Biohaven Pharmaceutical stock.
Which major investors are buying Biohaven Pharmaceutical stock?: Within the previous quarter, BHVN stock was acquired by institutional investors including:
American Century Companies Inc.
Eversept Partners LP
Clearbridge Investments LLC
Lord Abbett & CO. LLC
Sectoral Asset Management Inc.
Simplex Trading LLC
Suvretta Capital Management LLC
Emerald Advisers LLC

This Stock Under $2 Could Go to $20 (And STILL Be a SCREAMING BUY)

From Oxford Club | Ad

>>>

BHVN Insider Trading (Biohaven Pharmaceutical)

Biohaven Pharmaceutical Insider Trading History Chart

Biohaven Pharmaceutical Share Price & Price History

Biohaven Pharmaceutical Insider Trading History

SEC Filings (Institutional Ownership Changes) for Biohaven Pharmaceutical (NYSE:BHVN)

Institutional Buying and Selling by Quarter

Biohaven Pharmaceutical Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Biohaven Pharmaceutical?

Who are the major institutional investors of Biohaven Pharmaceutical?

Which major investors are selling Biohaven Pharmaceutical stock?

Which major investors are buying Biohaven Pharmaceutical stock?